INTERCEPT PHARMACEUTICALS IN (ICPT) Stock Price, Quote, News and Overview

What is the stock price of INTERCEPT PHARMACEUTICALS IN today?

The current stock price of ICPT is 19 USD. The price increased by 0.21% in the last trading session.

What is the ticker symbol for INTERCEPT PHARMACEUTICALS IN stock?

The exchange symbol of INTERCEPT PHARMACEUTICALS IN is ICPT and it is listed on the Nasdaq exchange.

On which exchange is ICPT stock listed?

ICPT stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for INTERCEPT PHARMACEUTICALS IN stock?

20 analysts have analysed ICPT and the average price target is 19.38 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 19. Check the INTERCEPT PHARMACEUTICALS IN stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is INTERCEPT PHARMACEUTICALS IN worth?

INTERCEPT PHARMACEUTICALS IN (ICPT) has a market capitalization of 794.39M USD. This makes ICPT a Small Cap stock.

How many employees does INTERCEPT PHARMACEUTICALS IN have?

INTERCEPT PHARMACEUTICALS IN (ICPT) currently has 341 employees.

What are the support and resistance levels for INTERCEPT PHARMACEUTICALS IN (ICPT) stock?

INTERCEPT PHARMACEUTICALS IN (ICPT) has a support level at 18.2 and a resistance level at 19.29. Check the full technical report for a detailed analysis of ICPT support and resistance levels.

Is INTERCEPT PHARMACEUTICALS IN (ICPT) expected to grow?

The Revenue of INTERCEPT PHARMACEUTICALS IN (ICPT) is expected to grow by 3.67% in the next year. Check the estimates tab for more information on the ICPT EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy INTERCEPT PHARMACEUTICALS IN (ICPT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of ICPT, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of ICPT, evaluating the profitability, health, valuation and growth aspects
• INTERCEPT PHARMACEUTICALS IN (ICPT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• INTERCEPT PHARMACEUTICALS IN (ICPT) Sales and EPS estimates to see what analysts future expectations are.
• INTERCEPT PHARMACEUTICALS IN (ICPT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• INTERCEPT PHARMACEUTICALS IN (ICPT) Insider and Institutional Ownership to learn about the owners and their transactions.
• INTERCEPT PHARMACEUTICALS IN (ICPT) Stock Chart to make your own analysis
• INTERCEPT PHARMACEUTICALS IN (ICPT) Latest news and press-releases to stay up to date.

Does INTERCEPT PHARMACEUTICALS IN (ICPT) stock pay dividends?

ICPT does not pay a dividend.

When does INTERCEPT PHARMACEUTICALS IN (ICPT) report earnings?

INTERCEPT PHARMACEUTICALS IN (ICPT) will report earnings on 2024-02-29, after the market close.

What is the Price/Earnings (PE) ratio of INTERCEPT PHARMACEUTICALS IN (ICPT)?

INTERCEPT PHARMACEUTICALS IN (ICPT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.33).

ChartMill assigns a fundamental rating of 2 / 10 to ICPT. ICPT may be in some trouble as it scores bad on both profitability and health.

Over the last trailing twelve months ICPT reported a non-GAAP Earnings per Share(EPS) of -1.33. The EPS decreased by -125.05% compared to the year before.

ChartMill assigns a Buy % Consensus number of 70% to ICPT. The Buy consensus is the average rating of analysts ratings from 20 analysts.

For the next year, analysts expect an EPS growth of -122.07% and a revenue growth 3.67% for ICPT